missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ BCAM Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA551119
This item is not returnable.
View return policy
Description
BCAM / CD239 Polyclonal Antibody detects endogenous levels of BCAM / CD239 protein.
Lutheran blood group glycoprotein is a member of the immunoglobulin superfamily and a receptor for the extracellular matrix protein, laminin. The protein contains five, N-terminus, extracellular immunoglobulin domains, a single transmembrane domain, and a short, C-terminal cytoplasmic tail. This protein may play a role in epithelial cell cancer and in vaso-occlusion of red blood cells in sickle cell disease. Two transcript variants encoding different isoforms have been found for this gene.
Specifications
| BCAM | |
| Polyclonal | |
| Unconjugated | |
| BCAM | |
| 1200005K12Rik; antigen identified by monoclonal antibody F8; AU; Auberger B antigen; basal cell adhesion molecule; basal cell adhesion molecule (Lu and Au blood groups); basal cell adhesion molecule (Lutheran blood group); basal cell adhesion molecule Lutheran blood group; BCAM; B-CAM; B-CAM cell surface glycoprotein; B-cell adhesion molecule; CD239; F8/G253 antigen; glycoprotein 95kDa; Gplu; LU; lutheran antigen; Lutheran blood group; Lutheran blood group (Auberger b antigen included); Lutheran blood group glycoprotein; Lutheran blood group variant LUGA; lutheran glycoprotein; MSK19 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 4059, 57278, 78958 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot | |
| 1 mg/mL | |
| PBS with 0.5% BSA, 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| P50895, Q9ESS6, Q9R069 | |
| BCAM | |
| Synthesized peptide derived from the Internal region of human CD239. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction